Brokers Set Expectations for NAGE Q3 Earnings
Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) - Research analysts at Roth Capital issued their Q3 2025 earnings per share estimates for shares of Niagen Bioscience in a research report issued on Tuesday, October 7th. Roth Capital analyst S. Mcgowan expects that the company will earn $0.01 per

What's Your Reaction?











